Cash flows from operating activities | |
Net earnings | |
Adjustments to reconcile net earnings to net cash provided by operating activities: | |
Depreciation of plant and equipment | 89.33M |
Amortization of intangibles | 26.07M |
Program production cost amortization | |
Deferred income taxes | 25.09M |
Stock-based compensation | 39.67M |
Change in operating assets and liabilities: | |
Decrease in accounts receivable | -224.17M |
Increase in inventories | -214.73M |
Increase in prepaid expenses and other current assets | -4.06M |
Program production costs | |
Decrease in accounts payable and accrued liabilities | 129.66M |
Other operating activities | |
Net cash provided by operating activities | |
Cash flows from investing activities | |
Additions to property, plant and equipment | -103.64M |
Investments and acquisitions, net of cash acquired | |
Other investing activities | 25.58M |
Net cash utilized by investing activities | |
Cash flows from financing activities | |
Net proceeds from borrowings with original maturities of more than three months | |
Repayments of borrowings with original maturities of more than three months | |
Net repayments from short-term borrowings | |
Purchases of common stock | -104.27M |
Stock option transactions | 37.52M |
Excess tax benefits from stock-based compensation | 19.71M |
Dividends paid | -185.27M |
Net cash (utilized) provided by financing activities | |
Effect of exchange rate changes on cash | 7.73M |
(Decrease) Increase in cash and cash equivalents | -146.38M |
Cash and cash equivalents at beginning of year | 976.75M |
Cash and cash equivalents at end of period | 830.37M |
Cash paid during the period for: | |
Interest | 74.7M |
Income taxes | 64.85M |